phase 2_initiation

Beijing StarMab BioMed Technology Ltd — SM-3321 (Phase II Trial Initiation)

April 26, 2026SM-3321updated 2mo ago

community read0 votes

Therapy area: Oncology. Indication: Advanced Malignancy, Solid Tumor

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

globaldata

Found something off?